Related Experiment Videos
Descriptive analysis and quantification of angiogenesis in human brain tumors
1Department of Pathology (Neuropathology), Brigham and Women's Hospital and Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. rdfolkerth@bics.bwh.harvard.edu
Journal of Neuro-Oncology
|March 14, 2001
Summary
Quantifying tumor vascularity in brain tumors offers prognostic insights beyond standard grading. This analysis highlights unique vessel features and their implications for anti-angiogenic therapy effectiveness.
Area of Science:
- Neuro-oncology
- Pathology
- Cancer Biology
Background:
- Tumor vascularity is a key prognostic indicator in many cancers.
- Endothelial proliferation, a measure of vascularity, is crucial for grading astrocytomas.
- Microvessel quantification in brain tumors requires further investigation for clinical utility.
Purpose of the Study:
- To review studies quantifying microvessel density in human brain tumors.
- To correlate microvessel quantification with clinical outcomes and pathobiologic factors.
- To explore the prognostic significance of vascularity in astrocytomas.
Main Methods:
- Systematic review of published literature on microvessel quantification in brain tumors.
- Analysis of studies correlating microvessel density with patient prognosis.
- Examination of pathobiologic factors related to tumor vascularity.
Main Results:
- Brain tumors exhibit unique glomeruloid vessels and heterogeneous microvascularity.
- Lower-grade astrocytomas may utilize existing vessels, while glioblastomas exhibit neovascularization.
- Microvessel quantification provides prognostic value independent of histologic grade in specific low-grade astrocytomas.
Conclusions:
- Quantitative vascularity assessment offers prognostic information in brain tumors.
- Understanding tumor angiogenesis is critical for developing targeted therapies.
- Findings support the potential role of anti-angiogenic therapies in specific brain tumor contexts.